Since 1924 — over one hundred years — the US dollar has lost nearly 18x its value. In other words, a dollar back then would buy $17.82 worth of goods in today's money. If you're planning on retiring any time soon…This poses a real problem.

Protect your retirement savings from the inevitable devaluation of the dollar…

ADPT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,435,243.14

Adaptive Biotechnologies Insider Trading History Chart

Adaptive Biotechnologies Share Price & Price History

^$3.18

▲ +0.07 (2.25%)

As of 05/8/2024 01:00 AM ET

Days: 30 | 90 | 365

Trump’s “Tax Free” Retirement Strategy

From Gold Safe Exchange | Ad

Protect your retirement savings from the inevitable devaluation of the dollar…

Adaptive Biotechnologies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2024	Chad M Robins	CEO	Sell	48,673	$3.43	$166,948.39	2,576,701
3/5/2024	Julie Rubinstein	President	Sell	39,070	$3.47	$135,572.90	472,754
3/5/2024	Kyle Piskel	Insider	Sell	7,727	$3.43	$26,503.61	123,318
3/5/2024	Stacy L. Taylor	SVP	Sell	13,381	$3.43	$45,896.83	166,287
3/5/2024	Tycho Peterson	CFO	Sell	15,456	$3.44	$53,168.64	531,553
11/16/2023	Kyle Piskel	Insider	Sell	259	$4.13	$1,069.67	87,305
8/7/2023	Nitin Sood	Insider	Sell	5,652	$6.78	$38,320.56	225,358
6/20/2023	Tycho Peterson	CFO	Sell	134,961	$8.14	$1,098,582.54	399,219
6/15/2023	Tycho Peterson	CFO	Sell	70,000	$8.53	$597,100.00	399,219
6/2/2023	Tycho Peterson	CFO	Sell	38,000	$7.16	$272,080.00	454,891
4/10/2023	R. Mark Adams	COO	Sell	817	$8.50	$6,944.50	177,669
3/27/2023	Michelle Renee Griffin	Director	Sell	2,341	$8.49	$19,875.09	20,627
3/6/2023	Julie Rubinstein	President	Sell	22,668	$8.57	$194,264.76	336,824
3/6/2023	Kyle Piskel	Insider	Sell	3,529	$8.57	$30,243.53	87,564
3/6/2023	R. Mark Adams	COO	Sell	6,529	$8.57	$55,953.53	195,641
3/6/2023	Stacy L. Taylor	SVP	Sell	5,491	$8.57	$47,057.87	153,065
1/9/2023	R. Mark Adams	COO	Sell	995	$8.50	$8,457.50	115,648
11/16/2022	Kyle Piskel	Insider	Sell	959	$8.87	$8,506.33	46,706
11/1/2022	Nitin Sood	Insider	Sell	31,066	$8.00	$248,528.00	114,505
10/10/2022	R. Mark Adams	COO	Sell	2,284	$7.13	$16,284.92	116,643
10/7/2022	R. Mark Adams	COO	Sell	841	$7.61	$6,400.01	118,927
8/5/2022	Nitin Sood	Insider	Sell	17,540	$10.98	$192,589.20	145,571
7/7/2022	R. Mark Adams	COO	Sell	825	$9.53	$7,862.25	122,068
4/7/2022	R. Mark Adams	COO	Sell	831	$13.17	$10,944.27	122,893
3/9/2022	Chad M Robins	CEO	Sell	14,815	$12.46	$184,594.90
3/7/2022	Chad M Robins	CEO	Sell	4,424	$12.01	$53,132.24
3/7/2022	Julie Rubinstein	President	Sell	4,613	$12.01	$55,402.13
3/7/2022	Lance Baldo	Insider	Sell	2,373	$12.01	$28,499.73
3/7/2022	R. Mark Adams	COO	Sell	1,244	$12.01	$14,940.44
3/7/2022	Stacy L. Taylor	SVP	Sell	1,569	$12.01	$18,843.69
12/22/2021	Chad M. Cohen	CFO	Sell	10,000	$30.00	$300,000.00
12/22/2021	Stacy L. Taylor	SVP	Sell	15,338	$30.00	$460,140.00
11/18/2021	Harlan S. Robins	Insider	Sell	300	$31.36	$9,408.00
11/9/2021	Chad M. Cohen	CFO	Sell	5,000	$36.03	$180,150.00
10/21/2021	Harlan S. Robins	Insider	Sell	3,700	$33.73	$124,801.00
10/19/2021	Harlan S. Robins	Insider	Sell	3,800	$33.69	$128,022.00
10/8/2021	Harlan S. Robins	Insider	Sell	3,895	$32.96	$128,379.20
10/7/2021	R. Mark Adams	COO	Sell	1,324	$32.47	$42,990.28
10/6/2021	Chad M. Cohen	CFO	Sell	5,000	$32.30	$161,500.00
10/6/2021	Harlan S. Robins	Insider	Sell	3,895	$32.27	$125,691.65
9/14/2021	Harlan S. Robins	Insider	Sell	3,895	$36.74	$143,102.30	73,255
9/10/2021	Chad M Robins	CEO	Sell	5,000	$38.38	$191,900.00	1,705,218
9/8/2021	Chad M Robins	CEO	Sell	13,746	$38.45	$528,533.70
9/7/2021	Chad M. Cohen	CFO	Sell	9,375	$39.71	$372,281.25	30,979
9/7/2021	Stacy L. Taylor	SVP	Sell	495	$40.00	$19,800.00
8/27/2021	Harlan S. Robins	Insider	Sell	3,895	$34.78	$135,468.10	73,255
8/27/2021	Michelle Renee Griffin	Director	Sell	14,916	$35.00	$522,060.00	16,420
8/25/2021	Harlan S. Robins	Insider	Sell	3,895	$34.09	$132,780.55
8/10/2021	Chad M. Cohen	CFO	Sell	5,000	$35.00	$175,000.00	26,604
7/21/2021	Harlan S. Robins	Insider	Sell	3,895	$37.82	$147,308.90	73,255
7/19/2021	Harlan S. Robins	Insider	Sell	3,895	$37.12	$144,582.40	73,255
7/19/2021	Jyoti Palaniappan	SVP	Sell	651	$36.12	$23,514.12	9,809
7/14/2021	Michelle Renee Griffin	Director	Sell	2,500	$36.80	$92,000.00
7/12/2021	Chad M. Robins	CEO	Sell	1,501	$38.24	$57,398.24	1,716,960
7/7/2021	Chad M. Cohen	CFO	Sell	10,000	$38.53	$385,300.00	31,604
7/7/2021	R. Mark Adams	COO	Sell	871	$39.42	$34,334.82
6/30/2021	Stacy L. Taylor	SVP	Sell	4,167	$41.42	$172,597.14
6/17/2021	Chad M Robins	CEO	Sell	5,255	$39.53	$207,730.15	1,729,361
6/17/2021	Michelle Renee Griffin	Director	Sell	4,000	$40.00	$160,000.00	5,504
6/17/2021	R. Mark Adams	COO	Sell	14,583	$40.00	$583,320.00	72,687
6/17/2021	Stacy L. Taylor	SVP	Sell	4,166	$40.00	$166,640.00	16,077
6/15/2021	Chad M. Robins	CEO	Sell	20,000	$38.27	$765,400.00	1,729,361
6/14/2021	Michelle Renee Griffin	Director	Sell	2,500	$38.56	$96,400.00	4,004
6/14/2021	R. Mark Adams	COO	Sell	8,914	$38.77	$345,595.78	58,104
6/11/2021	Harlan S. Robins	Insider	Sell	3,895	$38.41	$149,606.95	73,255
6/9/2021	Harlan S. Robins	Insider	Sell	3,895	$35.99	$140,181.05	73,255
6/8/2021	Chad M. Cohen	CFO	Sell	10,000	$37.05	$370,500.00	31,604
5/18/2021	Jyoti Palaniappan	SVP	Sell	651	$35.00	$22,785.00	9,809
5/18/2021	Michelle Renee Griffin	Director	Sell	2,500	$35.00	$87,500.00	4,004
5/14/2021	Francis Lo	Insider	Sell	2,000	$33.80	$67,600.00	22,604
5/12/2021	Chad M. Cohen	CFO	Sell	10,000	$32.63	$326,300.00	31,604

Trump’s “Tax Free” Retirement Strategy

From Gold Safe Exchange | Ad

Protect your retirement savings from the inevitable devaluation of the dollar…

SEC Filings (Institutional Ownership Changes) for Adaptive Biotechnologies (NASDAQ:ADPT)

99.17% of Adaptive Biotechnologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adaptive Biotechnologies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/7/2024	Susquehanna Fundamental Investments LLC	22,096	$71K	0.0%	N/A	0.015%
5/6/2024	Manchester Capital Management LLC	9,850	$32K	0.0%	N/A	0.007%
5/3/2024	Essex Investment Management Co. LLC	277,096	$0.89M	0.2%	+1.9%	0.188%
5/3/2024	Nikko Asset Management Americas Inc.	6,176,707	$19.77M	0.2%	-5.1%	4.191%
5/2/2024	Jennison Associates LLC	174,767	$0.56M	0.0%	+22.0%	0.119%
5/2/2024	Nordea Investment Management AB	859,214	$2.76M	0.0%	-1.1%	0.583%
5/2/2024	Moloney Securities Asset Management LLC	70,240	$0.23M	0.0%	N/A	0.048%
5/1/2024	BNP Paribas Financial Markets	63,141	$0.20M	0.0%	+48.8%	0.043%
5/1/2024	Mirae Asset Global Investments Co. Ltd.	50,479	$0.16M	0.0%	-7.2%	0.034%
4/29/2024	Principal Financial Group Inc.	32,504	$0.10M	0.0%	-93.4%	0.022%
4/29/2024	China Universal Asset Management Co. Ltd.	27,896	$90K	0.0%	+66.6%	0.019%
4/26/2024	Mesirow Financial Investment Management Inc.	18,715	$60K	0.0%	N/A	0.013%
4/19/2024	First Trust Direct Indexing L.P.	14,544	$47K	0.0%	N/A	0.010%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	6,176,707	$19.83M	0.0%	-5.1%	4.257%
2/15/2024	Blue Water Life Science Advisors LP	1,687,665	$8.27M	7.2%	-29.0%	1.166%
2/15/2024	Clear Street Markets LLC	20,491	$100K	0.0%	N/A	0.014%
2/14/2024	Braidwell LP	1,357,490	$6.65M	0.2%	+40.3%	0.938%
2/14/2024	Avenir Corp	66,365	$0.33M	0.0%	+117.1%	0.046%
2/14/2024	Personal CFO Solutions LLC	11,250	$55K	0.0%	N/A	0.008%
2/14/2024	Rubric Capital Management LP	2,862,729	$14.03M	0.3%	N/A	1.977%
2/12/2024	RPO LLC	16,016	$78K	0.1%	N/A	0.011%
2/12/2024	Pier 88 Investment Partners LLC	24,795	$0.12M	0.0%	-67.6%	0.017%
2/9/2024	D.A. Davidson & CO.	46,975	$0.23M	0.0%	-12.8%	0.032%
2/8/2024	Nikko Asset Management Americas Inc.	6,511,659	$31.91M	0.3%	-0.9%	4.498%
2/8/2024	Essex Investment Management Co. LLC	271,913	$1.33M	0.3%	+29.3%	0.188%
2/8/2024	Massachusetts Financial Services Co. MA	2,603,500	$12.76M	0.0%	+32.1%	1.798%
2/7/2024	Principal Financial Group Inc.	492,119	$2.41M	0.0%	-60.5%	0.340%
2/7/2024	QRG Capital Management Inc.	14,467	$71K	0.0%	N/A	0.010%
2/7/2024	Jump Financial LLC	35,666	$0.18M	0.0%	+51.2%	0.025%
2/7/2024	Versor Investments LP	25,100	$0.12M	0.0%	+32.1%	0.017%
2/7/2024	Calton & Associates Inc.	23,781	$0.12M	0.0%	N/A	0.016%
2/6/2024	Swiss National Bank	199,600	$0.98M	0.0%	-10.1%	0.138%
2/6/2024	Robertson Stephens Wealth Management LLC	183,786	$0.90M	0.1%	-8.0%	0.127%
2/5/2024	Victory Capital Management Inc.	19,087	$94K	0.0%	+22.5%	0.013%
2/5/2024	Brighton Jones LLC	25,885	$0.13M	0.0%	-36.5%	0.018%
2/5/2024	Russell Investments Group Ltd.	81,595	$0.40M	0.0%	+278.8%	0.056%
2/1/2024	New York State Common Retirement Fund	34,017	$0.17M	0.0%	-23.4%	0.023%
2/1/2024	Jennison Associates LLC	143,220	$0.70M	0.0%	+6.4%	0.099%
1/31/2024	abrdn plc	933,794	$4.58M	0.0%	N/A	0.645%
1/31/2024	Federated Hermes Inc.	1,212,660	$5.94M	0.0%	-12.5%	0.838%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	21,364	$0.11M	0.0%	+28.3%	0.015%
1/30/2024	Strs Ohio	87,500	$0.43M	0.0%	+4.5%	0.060%
1/30/2024	Sumitomo Mitsui Trust Holdings Inc.	6,511,659	$31.91M	0.0%	-0.9%	4.498%
1/26/2024	Cerity Partners LLC	135,652	$0.67M	0.0%	N/A	0.094%
1/26/2024	Peregrine Capital Management LLC	375,638	$1.84M	0.1%	-14.6%	0.259%
1/24/2024	China Universal Asset Management Co. Ltd.	16,747	$82K	0.0%	+350.3%	0.012%
1/23/2024	Lewis Asset Management LLC	19,500	$96K	0.1%	N/A	0.013%
1/18/2024	DDD Partners LLC	800,922	$3.93M	0.5%	+2.2%	0.553%
1/17/2024	ARK Investment Management LLC	12,806,513	$62.75M	0.4%	+11.3%	8.846%
1/17/2024	Assenagon Asset Management S.A.	844,852	$4.14M	0.0%	-2.3%	0.584%
1/16/2024	Legato Capital Management LLC	128,054	$0.63M	0.1%	+31.3%	0.088%
1/12/2024	SG Americas Securities LLC	70,571	$0.35M	0.0%	+20.2%	0.049%
1/10/2024	Nordea Investment Management AB	868,448	$4.39M	0.0%	-2.9%	0.600%
12/18/2023	Vanguard Group Inc.	12,249,042	$66.76M	0.0%	+1.6%	8.461%
12/6/2023	Citigroup Inc.	6,847	$37K	0.0%	-84.6%	0.005%
11/30/2023	American Century Companies Inc.	824,318	$4.49M	0.0%	+11.7%	0.569%
11/15/2023	AXQ Capital LP	10,600	$58K	0.0%	N/A	0.007%
11/14/2023	Lazard Asset Management LLC	199,360	$1.09M	0.0%	-2.9%	0.138%
11/14/2023	Braidwell LP	967,690	$5.27M	0.2%	+49.2%	0.669%
11/13/2023	Algert Global LLC	324,445	$1.77M	0.1%	+9.5%	0.224%
11/13/2023	Federated Hermes Inc.	1,385,207	$7.55M	0.0%	+24.5%	0.958%
11/13/2023	Dark Forest Capital Management LP	46,031	$0.25M	0.0%	N/A	0.032%
11/13/2023	Hsbc Holdings PLC	37,039	$0.20M	0.0%	+46.9%	0.026%
11/13/2023	Nordea Investment Management AB	894,071	$5.03M	0.0%	+133.0%	0.618%
11/9/2023	Skandinaviska Enskilda Banken AB publ	56,100	$0.31M	0.0%	-16.9%	0.039%
11/9/2023	Pier 88 Investment Partners LLC	76,495	$0.42M	0.1%	+6.8%	0.053%
11/9/2023	Blair William & Co. IL	63,664	$0.35M	0.0%	-17.4%	0.044%
11/8/2023	Charles Schwab Investment Management Inc.	859,067	$4.68M	0.0%	+2.5%	0.594%
11/8/2023	D.A. Davidson & CO.	53,875	$0.29M	0.0%	-35.3%	0.037%
11/8/2023	Massachusetts Financial Services Co. MA	1,971,460	$10.74M	0.0%	-7.0%	1.363%
11/8/2023	Swiss National Bank	222,100	$1.21M	0.0%	+1.7%	0.154%
11/7/2023	Barclays PLC	136,021	$0.74M	0.0%	+8.9%	0.094%
11/7/2023	Jump Financial LLC	23,594	$0.13M	0.0%	-45.5%	0.016%
11/7/2023	Savant Capital LLC	17,993	$98K	0.0%	N/A	0.012%
11/6/2023	Assenagon Asset Management S.A.	864,737	$4.71M	0.0%	+1,760.6%	0.598%
11/4/2023	Triatomic Management LP	102,889	$0.56M	0.4%	-15.1%	0.071%
11/2/2023	Principal Financial Group Inc.	1,246,864	$6.80M	0.0%	-0.7%	0.862%
10/31/2023	Jennison Associates LLC	134,625	$0.73M	0.0%	-13.6%	0.093%
10/30/2023	Sumitomo Mitsui Trust Holdings Inc.	6,570,939	$35.81M	0.0%	+2.9%	4.543%
10/27/2023	Allspring Global Investments Holdings LLC	11,459	$62K	0.0%	-46.3%	0.008%
10/27/2023	TD Asset Management Inc	31,494	$0.17M	0.0%	-51.5%	0.022%
10/24/2023	Bank of New York Mellon Corp	375,908	$2.05M	0.0%	+0.6%	0.260%
10/23/2023	Commonwealth Equity Services LLC	55,264	$0.30M	0.0%	+6.8%	0.038%
10/19/2023	Peregrine Capital Management LLC	439,955	$2.40M	0.1%	-5.8%	0.304%
10/18/2023	DDD Partners LLC	783,697	$4.27M	0.6%	N/A	0.542%
10/18/2023	ARK Investment Management LLC	11,509,308	$62.73M	0.5%	+10.1%	7.957%
10/13/2023	SG Americas Securities LLC	58,720	$0.32M	0.0%	+46.6%	0.041%
10/12/2023	Legato Capital Management LLC	97,494	$0.53M	0.1%	-2.5%	0.067%
10/11/2023	CWM LLC	5,731	$31K	0.0%	-96.6%	0.004%
9/21/2023	Barclays PLC	124,909	$0.84M	0.0%	-38.3%	0.086%
9/7/2023	Triatomic Management LP	121,166	$0.81M	0.8%	+4.0%	0.084%
8/14/2023	Caption Management LLC	18,200	$0.12M	0.0%	N/A	0.013%
8/14/2023	Aristotle Atlantic Partners LLC	3,104,961	$20.83M	0.8%	+62.8%	2.147%
8/14/2023	Cerity Partners LLC	211,241	$1.42M	0.0%	-3.9%	0.146%
8/14/2023	Prelude Capital Management LLC	31,804	$0.21M	0.0%	-10.3%	0.022%
8/11/2023	Robertson Stephens Wealth Management LLC	199,786	$1.34M	0.1%	-1.4%	0.138%
8/11/2023	Westwood Holdings Group Inc.	14,520	$97K	0.0%	-70.0%	0.010%
8/11/2023	D.A. Davidson & CO.	83,275	$0.56M	0.0%	+55.0%	0.058%
8/11/2023	ExodusPoint Capital Management LP	140,272	$0.94M	0.0%	+397.3%	0.097%
8/9/2023	TD Asset Management Inc	64,985	$0.44M	0.0%	-9.1%	0.045%

Data available starting January 2016

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It also provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.

Today's Range

Now: $3.18

$3.12

$3.77

50 Day Range

MA: $3.06

$2.34

$4.11

52 Week Range

Now: $3.18

$2.28

$9.08

Volume

2,146,355 shs

Average Volume

1,608,856 shs

Market Capitalization

$468.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Who are the company insiders with the largest holdings of Adaptive Biotechnologies?: Adaptive Biotechnologies' top insider shareholders include:
Chad M Robins (CEO)
Tycho Peterson (CFO)
Julie Rubinstein (President)
Nitin Sood (Insider)
R Mark Adams (COO)
Stacy L Taylor (SVP)
Kyle Piskel (Insider)
Michelle Renee Griffin (Director)
Learn More about top insider investors at Adaptive Biotechnologies.
Who are the major institutional investors of Adaptive Biotechnologies?: Adaptive Biotechnologies' top institutional investors include:
Sumitomo Mitsui Trust Holdings Inc. — 4.26%
Nikko Asset Management Americas Inc. — 4.19%
Nordea Investment Management AB — 0.58%
Essex Investment Management Co. LLC — 0.19%
Jennison Associates LLC — 0.12%
Moloney Securities Asset Management LLC — 0.05%
Learn More about top institutional investors of Adaptive Biotechnologies stock.
Which major investors are selling Adaptive Biotechnologies stock?: Within the last quarter, ADPT stock was sold by these institutional investors:
Principal Financial Group Inc.
Sumitomo Mitsui Trust Holdings Inc.
Nikko Asset Management Americas Inc.
Nordea Investment Management AB
Mirae Asset Global Investments Co. Ltd.
Within the last year, company insiders that have sold Adaptive Biotechnologies company stock include:
Chad M Robins (CEO)
Tycho Peterson (CFO)
Julie Rubinstein (President)
Nitin Sood (Insider)
R Mark Adams (COO)
Stacy L Taylor (SVP)
Learn More investors selling Adaptive Biotechnologies stock.
Which major investors are buying Adaptive Biotechnologies stock?: Within the previous quarter, ADPT stock was acquired by institutional investors including:
Moloney Securities Asset Management LLC
Jennison Associates LLC
Susquehanna Fundamental Investments LLC
BNP Paribas Financial Markets
Mesirow Financial Investment Management Inc.
First Trust Direct Indexing L.P.
China Universal Asset Management Co. Ltd.
Manchester Capital Management LLC

Trump’s “Tax Free” Retirement Strategy

From Gold Safe Exchange | Ad

Protect your retirement savings from the inevitable devaluation of the dollar…

ADPT Insider Trading

Adaptive Biotechnologies Insider Trading History Chart

Adaptive Biotechnologies Share Price & Price History

Adaptive Biotechnologies Insider Trading History

SEC Filings (Institutional Ownership Changes) for Adaptive Biotechnologies (NASDAQ:ADPT)

Institutional Buying and Selling by Quarter

Adaptive Biotechnologies Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Adaptive Biotechnologies?

Who are the major institutional investors of Adaptive Biotechnologies?

Which major investors are selling Adaptive Biotechnologies stock?

Which major investors are buying Adaptive Biotechnologies stock?